These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 15093804)

  • 21. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis.
    Ye F; Ying-Bin X; Yu-Guo W; Hetzer R
    J Heart Lung Transplant; 2009 Jan; 28(1):58-66. PubMed ID: 19134532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and prophylaxis of cardiac allograft vasculopathy.
    Wang SS
    Transplant Proc; 2008 Oct; 40(8):2609-10. PubMed ID: 18929815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the treatment and management of new-onset diabetes after transplantation.
    Wilkinson A; Davidson J; Dotta F; Home PD; Keown P; Kiberd B; Jardine A; Levitt N; Marchetti P; Markell M; Naicker S; O'Connell P; Schnitzler M; Standl E; Torregosa JV; Uchida K; Valantine H; Villamil F; Vincenti F; Wissing M
    Clin Transplant; 2005 Jun; 19(3):291-8. PubMed ID: 15877787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk profile for cardiovascular morbidity and mortality after lung transplantation.
    De Vito Dabbs A; Song MK
    Nurs Clin North Am; 2008 Mar; 43(1):37-53; vi. PubMed ID: 18249224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients.
    Ye X; Kuo HT; Sampaio MS; Jiang Y; Reddy P; Bunnapradist S
    Transplantation; 2010 Jun; 89(12):1526-32. PubMed ID: 20431437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.
    Kobashigawa JA; Starling RC; Mehra MR; Kormos RL; Bhat G; Barr ML; Sigouin CS; Kolesar J; Fitzsimmons W
    J Heart Lung Transplant; 2006 Sep; 25(9):1063-9. PubMed ID: 16962467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk estimates and risk factors in renal transplant recipients.
    Krämer BK; Böger C; Krüger B; Marienhagen J; Pietrzyk M; Obed A; Paczek L; Mack M; Banas B
    Transplant Proc; 2005 May; 37(4):1868-70. PubMed ID: 15919488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors.
    Eisen H; Kobashigawa J; Starling RC; Valantine H; Mancini D
    Transplant Proc; 2005 May; 37(4 Suppl):4S-17S. PubMed ID: 15809102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Hathout E; Beeson WL; Kuhn M; Johnston J; Fitts J; Razzouk A; Bailey L; Chinnock RE
    Transpl Int; 2006 Mar; 19(3):184-9. PubMed ID: 16441766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
    Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac allograft vasculopathy: current knowledge and future direction.
    Colvin-Adams M; Agnihotri A
    Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
    Kushwaha SS; Khalpey Z; Frantz RP; Rodeheffer RJ; Clavell AL; Daly RC; McGregor CG; Edwards BS
    J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.
    Arora S; Jenum PA; Aukrust P; Rollag H; Andreassen AK; Simonsen S; Gude E; Fiane AE; Geiran O; Gullestad L
    J Am Coll Cardiol; 2007 Nov; 50(20):1967-72. PubMed ID: 17996562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
    Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
    J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.